What is it about?

In a randomized, controlled trial, patients safely lowered their HbA1c using a smartphone app that delivers personalized cognitive behavioral therapy.

Featured Image

Read the Original

This page is a summary of: Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes, Diabetes Care, October 2022, American Diabetes Association,
DOI: 10.2337/dc22-1099.
You can read the full text:

Read

Contributors

Be the first to contribute to this page